Chemocentryx Operating Margin

CCXI -  USA Stock  

USD 17.19  0.11  0.64%

Chemocentryx fundamentals help investors to digest information that contributes to Chemocentryx's financial success or failures. It also enables traders to predict the movement of Chemocentryx Stock. This fundamental analysis module provides a way for investors to measures Chemocentryx's intrinsic value by examining all of its available economic and financial indicators and drivers, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Chemocentryx stock. Please note, this module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Search Operating Margin 

 
Refresh
The current Operating Margin is estimated to decrease to -100.36.

Chemocentryx Operating Margin Analysis

Chemocentryx's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.

Chemocentryx Operating Margin

(100.36)Share
Operating Margin 
 = 
Operating Income 
Revenue 
X
100 
More About Operating Margin | All Equity Analysis

Current Chemocentryx Operating Margin

    
  (90.10) %  
Most of Chemocentryx's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Chemocentryx is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Chemocentryx Operating Margin Driver Correlations

Understanding the fundamental principles of building solid financial models for Chemocentryx is extremely important. It helps to project a fair market value of Ford stock properly, considering its historical fundamentals such as Operating Margin. Since Chemocentryx's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Chemocentryx's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Chemocentryx's interrelated accounts and indicators.

Chemocentryx Operating Margin Historical Pattern

Today, most investors in Chemocentryx Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Chemocentryx's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's operating margin growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Chemocentryx operating margin as a starting point in their analysis.
 Chemocentryx Operating Margin 
Share
      Timeline 
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Compare to competition

Based on the recorded statements, Chemocentryx has an Operating Margin of -90.1%. This is 156.84% higher than that of the Healthcare sector and 19.6% lower than that of the Biotechnology industry. The operating margin for all United States stocks is notably higher than that of the company.

Chemocentryx Current Valuation Drivers

We derive many important indicators used in calculating different scores of Chemocentryx from analyzing Chemocentryx's financial statements. These drivers represent accounts that assess Chemocentryx's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Chemocentryx's important valuation drivers and their relationship over time.
201620172018201920202021 (projected)
Net Income Per Employee(642.8 K)270.59 K(499.55 K)(676.7 K)(415.07 K)(447.84 K)
Average Assets124.81 M152.54 M190.61 M223.14 M447.82 M483.18 M
Earnings Before Interest Taxes and Depreciation Amortization EBITDA(39.62 M)18.28 M(36.23 M)(51.7 M)(49.95 M)(51.26 M)
Earnings Before Interest Taxes and Depreciation Amortization USD(39.62 M)18.28 M(36.23 M)(51.7 M)(49.95 M)(51.26 M)
Earnings before Tax(39.96 M)17.86 M(37.97 M)(55.49 M)(55.36 M)(56.81 M)
Average Equity55.9 M50.95 M22.66 M69.99 M317.93 M343.03 M
Enterprise Value339.9 M272.2 M541.85 M2.29 B4.29 B4.63 B
Free Cash Flow38.84 M4.16 M15.6 M(70.91 M)(96.55 M)(99.09 M)
Invested Capital105.51 M121.05 M110.52 M131.18 M498.12 M537.44 M
Invested Capital Average85.79 M87.97 M98.42 M135.44 M323.79 M349.35 M
Market Capitalization353.76 M290.16 M551.24 M2.3 B4.29 B4.62 B
Tangible Asset Value155.87 M189.33 M183.31 M209.08 M518.9 M559.86 M
Working Capital110.36 M146.89 M116.99 M115.28 M390.01 M420.8 M

Chemocentryx Fundamentals

About Chemocentryx Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Chemocentryx's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Chemocentryx using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Chemocentryx based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for 2021
Operating Margin(97.78) (100.36) 
ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. ChemoCentryx, Inc. was incorporated in 1996 and is headquartered in Mountain View, California. Chemocentryx operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 133 people.

Chemocentryx Investors Sentiment

The influence of Chemocentryx's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Chemocentryx. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Current Sentiment - CCXI

Chemocentryx Investor Sentiment

Most of Macroaxis users are currently bullish on Chemocentryx. What is your opinion about investing in Chemocentryx? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Pair Trading with Chemocentryx

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Chemocentryx position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chemocentryx will appreciate offsetting losses from the drop in the long position's value.

Chemocentryx Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Chemocentryx and Dynavax Technologies. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Continue to Chemocentryx Piotroski F Score and Chemocentryx Altman Z Score analysis. Note that the Chemocentryx information on this page should be used as a complementary analysis to other Chemocentryx's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Complementary Tools for Chemocentryx Stock analysis

When running Chemocentryx price analysis, check to measure Chemocentryx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemocentryx is operating at the current time. Most of Chemocentryx's value examination focuses on studying past and present price action to predict the probability of Chemocentryx's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Chemocentryx's price. Additionally, you may evaluate how the addition of Chemocentryx to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
The market value of Chemocentryx is measured differently than its book value, which is the value of Chemocentryx that is recorded on the company's balance sheet. Investors also form their own opinion of Chemocentryx's value that differs from its market value or its book value, called intrinsic value, which is Chemocentryx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemocentryx's market value can be influenced by many factors that don't directly affect Chemocentryx underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemocentryx's value and its price as these two are different measures arrived at by different means. Investors typically determine Chemocentryx value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemocentryx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.